Showing results (211-220 of 296) with videos related to

Sort By:
Pageof 30
Progress in Biochemical Pharmacology|January 1, 1976
Effects of angiotensin antagonists in various forms of experimental arterial hypertensionC M Ferrario, F M Bumpus, Z Masaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Astrocyte cultures derived from human brain tissue express angiotensinogen mRNAA Milsted, B P Barna, R M Ransohoff, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1983
Basal levels of plasma epinephrine and norepinephrine in the dogP A Bridle, K B Brosnihan, R C Speth, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Alterations in cardiac function and cardiopulmonary blood volume in chronic sodium depletion in dogsM P Lynn, F Fouad, S A Cook, et al.
American Journal of Hypertension|March 1, 1991
The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesisN Jaiswal, D I Diz, E A Tallant, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involvedN Jaiswal, E A Tallant, R K Jaiswal, et al.
Journal of Hypertension|June 1, 1996
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertensionM Luque, P Martin, N Martell, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 11, 2008
Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in ratsJ Joyner, L A A Neves, K Stovall, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1987
Changes in hemodynamics and myocardial contractility during chronic sodium depletion in conscious dogsT Nii, F M Fouad-Tarazi, C M Ferrario, et al.
Circulation|November 1, 1995
Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research GroupJ M Flack, J Neaton, R Grimm, et al.
Pageof 30